CVS Stock Chart & Fundamental Analysis

Interactive Chart

About CVS Health Corporation

Name

CVS Health Corporation

CEO

J. David Joyner

Website

www.cvshealth.com

Industry

Healthcare

Year Founded

1963

Employees

259,500

CVS Health Corporation (NYSE: CVS) is a U.S. healthcare company that combines insurance, pharmacy benefits, and retail pharmacy and clinic operations. In FY2025, it generated $402.1 billion in revenue. Its business spans managed care, prescription fulfillment, and consumer health products within the healthcare plans and services market.

Analyst Ratings

Consensus Recommendation

Buy3

Hold1

Sell4

Fundamentals & Financials

Revenue (TTM)

$415B

Net Income (TTM)

$4.9B

EPS (TTM)

$3.83

ROA (TTM)

1.93%

Current Ratio

0.87

Dividend Yield

0.67%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement

Item	Q2 FY2026	Q1 FY2026	Q4 FY2025
Revenue	$106,096M	$100,426M	$105,693M
Cost of Sales	$90,347M	$84,802M	$92,126M
Gross Profit	$15,749M	$15,624M	$13,567M
Operating Income	$4,703M	$4,680M	$2,112M
Net Income	$2,995M	$2,943M	$2,943M
EPS	$2.33	$2.31	$2.32

Balance Sheet

Financial Highlights

Dividends History

Split History

Earnings Calendar

Technical Indicators

CVS Health Corporation's Technical Indicators Summary

CVS shows a Sell bias driven by clear short- and medium-term weakness, with the price below most near-term moving averages while longer-term averages remain lower. Momentum measures are tilted bearish—MACD and momentum readings are negative and RSI sits subdued—while ADX signals a relatively strong directional move to the downside. Volatility is moderate and OBV is negative, indicating distribution rather than support; oscillators flag short-term oversold conditions but the weight of trend and volume is negative. Technical takeaway: Sell — downward pressure is confirmed by trend strength and volume despite oversold oscillators.

Buy

3 signals

Neutral

1 signal

Sell

4 signals

Overall: Bearish50% Bearish signals

Indicator	Value	Signal	Explanation
RSI (14)	37.52	Neutral	RSI (37.52) is neutral.
Stochastic %K (14, 3, 3)	15.07	Buy	Stochastic (15.07) < 20, indicating oversold.
CCI (20)	-78.17	—	CCI (-78.17) is neutral.
WPR (14)	-85.11	—	Williams %R (-85.11) < -80, indicating oversold.
Momentum (10)	-9.51	—	Momentum (-9.51) is negative.
MFI	44.41	—	MFI (44.41) is neutral.
MACD Level (12, 26)	-2.53	Sell	Confirmed downtrend: MACD (-2.53) is negative and below its signal line (-1.66).
Bollinger Bands	$89.45 - $112.60	—	Price is within the bands.
ATR (14)	$2.79 (2.93%)	—	Moderate Volatility (2.93%).
ADX (14)	35.53	—	Strong downtrend (ADX > 25) with bearish directional movement. ADX(35.53), +DI(13.28), -DI(29.79)
OBV	250,074,441	—	Bearish volume pressure: OBV is below its 20-day SMA. OBV(250,074,441), 20D-SMA-OBV(270,947,583)
Classic Pivot Point	$94.75	—	Price ($94.91) hovering around equilibrium (P: $94.75) — no clear directional bias.
Fibonacci Pivot Point	$94.75	—	Price ($94.91) hovering around equilibrium (P: $94.75) — no clear directional bias.
Simple Moving Averages	$85.50 - $102.25(5 indicators)	—	SMA group: 3/5 bearish, 2 bullish, 0 neutral. Price below key SMA averages.
Exponential Moving Averages	$88.14 - $99.37(5 indicators)	Sell	EMA group: 3/5 bearish, 2 bullish, 0 neutral. Price below key EMA averages.

Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.

Today's Snapshot

A marginally positive tone marked the last session, with CVS closing slightly higher at 94.91. CVS adds JPMorgan's Teresa Heitsenrether as a data-and-analytics board member.

Trading Volume

Below 10d avg (9.5M)

vs S&P 500 Today

Outperforming Market

+1.65%

52-Week Position

Mid-range

61.7%

Updated: August 19, 2026 at 12:14 UTC